{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:00:20Z","timestamp":1773795620718,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s12010-025-05535-3","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T08:54:45Z","timestamp":1767948885000},"page":"1994-2016","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tanshinone I Promotes Ferroptosis of Cervical Cancer Cells by Activating the ATF3-Mediated Transcriptional Inhibition of FSP1"],"prefix":"10.1007","volume":"198","author":[{"given":"Jia","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixia","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7417-2739","authenticated-orcid":false,"given":"Juanzi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"5535_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71, 209\u2013249.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"5535_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","volume":"35","author":"F Yang","year":"2023","unstructured":"Yang, F., Xiao, Y., Ding, J. H., Jin, X., Ma, D., Li, D. Q., Shi, J. X., Huang, W., Wang, Y. P., Jiang, Y. Z., & Shao, Z. M. (2023). Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy. Cell Metab, 35, 84\u2013100e108.","journal-title":"Cell Metab"},{"key":"5535_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bbrc.2021.01.028","volume":"545","author":"J Xiaofei","year":"2021","unstructured":"Xiaofei, J., Mingqing, S., Miao, S., Yizhen, Y., Shuang, Z., Qinhua, X., & Kai, Z. (2021). Oleanolic acid inhibits cervical cancer Hela cell proliferation through modulation of the ACSL4 ferroptosis signaling pathway. Biochemical and Biophysical Research Communications, 545, 81\u201388.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"5535_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-019-0270-9","volume":"14","author":"H Luo","year":"2019","unstructured":"Luo, H., Vong, C. T., Chen, H., Gao, Y., Lyu, P., Qiu, L., Zhao, M., Liu, Q., Cheng, Z., Zou, J., Yao, P., Gao, C., Wei, J., Ung, C. O. L., Wang, S., Zhong, Z., & Wang, Y. (2019). Naturally occurring anti-cancer compounds: Shining from Chinese herbal medicine. Chinese Medicine, 14, Article 48.","journal-title":"Chinese Medicine"},{"key":"5535_CR5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2217\/nnm.15.185","volume":"11","author":"Y Cai","year":"2016","unstructured":"Cai, Y., Zhang, W., Chen, Z., Shi, Z., He, C., & Chen, M. (2016). Recent insights into the biological activities and drug delivery systems of tanshinones. International Journal of Nanomedicine, 11, 121\u2013130.","journal-title":"International Journal of Nanomedicine"},{"key":"5535_CR6","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.biopha.2017.06.040","volume":"93","author":"Y Wei","year":"2017","unstructured":"Wei, Y., Gao, J., Qin, L., Xu, Y., Wang, D., Shi, H., Xu, T., & Liu, T. (2017). Tanshinone I alleviates insulin resistance in type 2 diabetes mellitus rats through IRS-1 pathway. Biomedicine & Pharmacotherapy, 93, 352\u2013358.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"5535_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12739","volume":"53","author":"J Zhou","year":"2020","unstructured":"Zhou, J., Jiang, Y. Y., Chen, H., Wu, Y. C., & Zhang, L. (2020). Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K\/AKT\/mTOR pathway. Cell Proliferation, 53, Article e12739.","journal-title":"Cell Proliferation"},{"key":"5535_CR8","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/CAD.0000000000000908","volume":"31","author":"L Zheng","year":"2020","unstructured":"Zheng, L., Zhang, Y., Liu, G., Cheng, S., Zhang, G., An, C., Sun, S., Wang, J., Pang, B., & Li, S. (2020). Tanshinone I regulates autophagic signaling via the activation of AMP-activated protein kinase in cancer cells. Anti-Cancer Drugs, 31, 601\u2013608.","journal-title":"Anti-Cancer Drugs"},{"key":"5535_CR9","doi-asserted-by":"crossref","unstructured":"Wang, G., Li, Y., Guo, Z., He, Q., Liu, Z., & Deng, B. (2024). Tanshinone I stimulates pyroptosis of Cisplatin-Resistant gastric cancer cells by activating the NF-\u03baB\/Caspase-3(8)\/GSDME signaling pathway. DNA and cell biology.","DOI":"10.1089\/dna.2023.0293"},{"key":"5535_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-021-04257-4","volume":"477","author":"B Ye","year":"2022","unstructured":"Ye, B., Qiao, K., Zhao, Q., Jiang, Z., Hu, N., & Wang, F. (2022). Tanshinone I restrains osteosarcoma progression by regulating circ_0000376\/miR-432-5p\/BCL2 axis. Molecular and Cellular Biochemistry, 477, 1\u201313.","journal-title":"Molecular and Cellular Biochemistry"},{"key":"5535_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.153958","volume":"98","author":"S Cui","year":"2022","unstructured":"Cui, S., Chen, T., Wang, M., Chen, Y., Zheng, Q., Feng, X., Li, S., & Wang, J. (2022). Tanshinone I inhibits metastasis of cervical cancer cells by inducing BNIP3\/NIX-mediated mitophagy and reprogramming mitochondrial metabolism. Phytomedicine, 98, Article 153958.","journal-title":"Phytomedicine"},{"key":"5535_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22267","volume":"33","author":"S Dun","year":"2019","unstructured":"Dun, S., & Gao, L. (2019). Tanshinone I attenuates proliferation and chemoresistance of cervical cancer in a KRAS-dependent manner. Journal of Biochemical and Molecular Toxicology, 33, Article e22267.","journal-title":"Journal of Biochemical and Molecular Toxicology"},{"key":"5535_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01597-6","volume":"9","author":"K Tian","year":"2023","unstructured":"Tian, K., Wei, J., Wang, R., Wei, M., Hou, F., & Wu, L. (2023). Sophoridine derivative 6j inhibits liver cancer cell proliferation via ATF3 mediated ferroptosis. Cell Death Discovery, 9, Article 296.","journal-title":"Cell Death Discovery"},{"key":"5535_CR14","doi-asserted-by":"publisher","DOI":"10.1177\/09603271231216963","volume":"42","author":"M Xia","year":"2023","unstructured":"Xia, M., Wu, Y., Zhu, H., & Duan, W. (2023). Tanshinone I induces ferroptosis in gastric cancer cells via the KDM4D\/p53 pathway. Human & Experimental Toxicology, 42, Article 9603271231216963.","journal-title":"Human & Experimental Toxicology"},{"key":"5535_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1282203","volume":"14","author":"P Zhang","year":"2023","unstructured":"Zhang, P., Liu, W., & Wang, Y. (2023). The mechanisms of tanshinone in the treatment of tumors. Frontiers in Pharmacology, 14, Article 1282203.","journal-title":"Frontiers in Pharmacology"},{"key":"5535_CR16","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00280-016-3034-6","volume":"77","author":"X Jing","year":"2016","unstructured":"Jing, X., Xu, Y., Cheng, W., Guo, S., Zou, Y., & He, L. (2016). Tanshinone I induces apoptosis and pro-survival autophagy in gastric cancers. Cancer Chemotherapy and Pharmacology, 77, 1171\u20131181.","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"5535_CR17","doi-asserted-by":"publisher","first-page":"12224","DOI":"10.1080\/21655979.2022.2074619","volume":"13","author":"Y Li","year":"2022","unstructured":"Li, Y., Deng, X., Zhuang, W., Li, Y., Xue, H., Lv, X., & Zhu, S. (2022). Tanshinone IIA down-regulates -transforming growth factor beta 1 to relieve renal tubular epithelial cell inflammation and pyroptosis caused by high glucose. Bioengineered, 13, 12224\u201312236.","journal-title":"Bioengineered"},{"key":"5535_CR18","doi-asserted-by":"crossref","unstructured":"Guan, Z., Chen, J., Li, X., & Dong, N. (2020). Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation. Bioscience Reports, 40.","DOI":"10.1042\/BSR20201807"},{"key":"5535_CR19","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2022.11449","volume":"24","author":"W Mao","year":"2022","unstructured":"Mao, W., Ding, J., Li, Y., Huang, R., & Wang, B. (2022). Inhibition of cell survival and invasion by Tanshinone IIA via FTH1: A key therapeutic target and biomarker in head and neck squamous cell carcinoma. Experimental and Therapeutic Medicine, 24, Article 521.","journal-title":"Experimental and Therapeutic Medicine"},{"key":"5535_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2271613","volume":"15","author":"T Zhang","year":"2023","unstructured":"Zhang, T., Gao, G., Kwok, L. Y., & Sun, Z. (2023). Gut microbiome-targeted therapies for Alzheimer\u2019s disease. Gut Microbes, 15, Article 2271613.","journal-title":"Gut Microbes"},{"key":"5535_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2021.08.067","volume":"575","author":"L He","year":"2021","unstructured":"He, L., Liu, Y. Y., Wang, K., Li, C., Zhang, W., Li, Z. Z., Huang, X. Z., & Xiong, Y. (2021). Tanshinone IIA protects human coronary artery endothelial cells from ferroptosis by activating the NRF2 pathway. Biochemical and Biophysical Research Communications, 575, 1\u20137.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"5535_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jcmgh.2023.03.001","volume":"16","author":"JW Cheu","year":"2023","unstructured":"Cheu, J. W., Lee, D., Li, Q., Goh, C. C., Bao, M. H., Yuen, V. W., Zhang, M. S., Yang, C., Chan, C. Y., Tse, A. P., Sit, G. F., Liu, C. X., Ng, I. O., Wong, C. M., & Wong, C. C. (2023). Ferroptosis suppressor protein 1 inhibition promotes tumor ferroptosis and anti-tumor immune responses in liver cancer. Cellular and Molecular Gastroenterology and Hepatology, 16, 133\u2013159.","journal-title":"Cellular and Molecular Gastroenterology and Hepatology"},{"key":"5535_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216147","volume":"561","author":"R Zhang","year":"2023","unstructured":"Zhang, R., Kang, R., & Tang, D. (2023). Ferroptosis in gastrointestinal cancer: From mechanisms to implications. Cancer Lett., 561, Article 216147.","journal-title":"Cancer Lett."},{"key":"5535_CR24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41556-023-01314-6","volume":"26","author":"W Cui","year":"2024","unstructured":"Cui, W., Guo, M., Liu, D., Xiao, P., Yang, C., Huang, H., Liang, C., Yang, Y., Fu, X., Zhang, Y., Liu, J., Shi, S., Cong, J., Han, Z., Xu, Y., Du, L., Yin, C., Zhang, Y., Sun, J., \u2026 Chu, B. (2024). Gut microbial metabolite facilitates colorectal cancer development via ferroptosis inhibition. Nature Cell Biology, 26, 124\u2013137.","journal-title":"Nature Cell Biology"},{"key":"5535_CR25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ejpb.2023.07.014","volume":"190","author":"QF Huang","year":"2023","unstructured":"Huang, Q. F., Li, Y. H., Huang, Z. J., Jun, M., Wang, W., Chen, X. L., & Wang, G. H. (2023). Artesunate carriers induced ferroptosis to overcome biological barriers for anti-cancer. European Journal of Pharmaceutics and Biopharmaceutics, 190, 284\u2013293.","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"5535_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.14218\/JCTH.2023.00162","volume":"12","author":"Y Wang","year":"2024","unstructured":"Wang, Y., Li, Y., Qiu, Y., Shen, M., Wang, L., Shao, J., Zhang, F., Xu, X., Zhang, Z., Guo, M., & Zheng, S. (2024). Artesunate induces ferroptosis in hepatic stellate cells and alleviates liver fibrosis via the ROCK1\/ATF3 axis. Journal of Clinical and Translational Hepatology, 12, 36\u201351.","journal-title":"Journal of Clinical and Translational Hepatology"},{"key":"5535_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1177-1","volume":"21","author":"A Nagpal","year":"2019","unstructured":"Nagpal, A., Redvers, R. P., Ling, X., Ayton, S., Fuentes, M., Tavancheh, E., Diala, I., Lalani, A., Loi, S., David, S., Anderson, R. L., Smith, Y., Merino, D., Denoyer, D., & Pouliot, N. (2019). Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2(+\u2009ve) breast cancer metastasis. Breast Cancer Research, 21, Article 94.","journal-title":"Breast Cancer Research"},{"key":"5535_CR28","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1002\/ijc.28159","volume":"133","author":"C Louandre","year":"2013","unstructured":"Louandre, C., Ezzoukhry, Z., Godin, C., Barbare, J. C., Maziere, J. C., Chauffert, B., & Galmiche, A. (2013). Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib. International Journal of Cancer, 133, 1732\u20131742.","journal-title":"International Journal of Cancer"},{"key":"5535_CR29","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1038\/s41401-021-00700-w","volume":"42","author":"S Lu","year":"2021","unstructured":"Lu, S., Wang, X. Z., He, C., Wang, L., Liang, S. P., Wang, C. C., Li, C., Luo, T. F., Feng, C. S., Wang, Z. C., Chi, G. F., & Ge, P. F. (2021). ATF3 contributes to brucine-triggered glioma cell ferroptosis via promotion of hydrogen peroxide and iron. Acta Pharmacologica Sinica, 42, 1690\u20131702.","journal-title":"Acta Pharmacologica Sinica"},{"key":"5535_CR30","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41418-019-0380-z","volume":"27","author":"L Wang","year":"2020","unstructured":"Wang, L., Liu, Y., Du, T., Yang, H., Lei, L., Guo, M., Ding, H. F., Zhang, J., Wang, H., Chen, X., & Yan, C. (2020). ATF3 promotes erastin-induced ferroptosis by suppressing system Xc(). Cell Death and Differentiation, 27, 662\u2013675.","journal-title":"Cell Death and Differentiation"},{"key":"5535_CR31","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jconrel.2023.12.038","volume":"366","author":"X Zhao","year":"2024","unstructured":"Zhao, X., Wang, Z., Wu, G., Yin, L., Xu, L., Wang, N., & Peng, J. (2024). Apigenin-7-glucoside-loaded nanoparticle alleviates intestinal ischemia-reperfusion by ATF3\/SLC7A11-mediated ferroptosis. Journal of Controlled Release : Official Journal of the Controlled Release Society, 366, 182\u2013193.","journal-title":"Journal of Controlled Release : Official Journal of the Controlled Release Society"},{"key":"5535_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110588","volume":"382","author":"X Qian","year":"2023","unstructured":"Qian, X., Zhu, L., Xu, M., Liu, H., Yu, X., Shao, Q., & Qin, J. (2023). Shikonin suppresses small cell lung cancer growth via inducing ATF3-mediated ferroptosis to promote ROS accumulation. Chemico-Biological Interactions, 382, Article 110588.","journal-title":"Chemico-Biological Interactions"},{"key":"5535_CR33","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1007\/s12094-023-03136-2","volume":"25","author":"J Zang","year":"2023","unstructured":"Zang, J., Cui, M., Xiao, L., Zhang, J., & Jing, R. (2023). Overexpression of ferroptosis-related genes FSP1 and CISD1 is related to prognosis and tumor immune infiltration in gastric cancer. Clinical and Translational Oncology, 25, 2532\u20132544.","journal-title":"Clinical and Translational Oncology"},{"key":"5535_CR34","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41418-024-01263-z","volume":"31","author":"H Miao","year":"2024","unstructured":"Miao, H., Meng, H., Zhang, Y., Chen, T., Zhang, L., & Cheng, W. (2024). FSP1 inhibition enhances olaparib sensitivity in BRCA-proficient ovarian cancer patients via a nonferroptosis mechanism. Cell Death & Differentiation, 31, 497\u2013510.","journal-title":"Cell Death & Differentiation"},{"key":"5535_CR35","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.molmed.2023.05.013","volume":"29","author":"W Li","year":"2023","unstructured":"Li, W., Liang, L., Liu, S., Yi, H., & Zhou, Y. (2023). FSP1: A key regulator of ferroptosis. Trends in Molecular Medicine, 29, 753\u2013764.","journal-title":"Trends in Molecular Medicine"},{"key":"5535_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3373828","volume":"2022","author":"PW Ma","year":"2022","unstructured":"Ma, P. W., Wang, W. L., Chen, J. W., Yuan, H., Lu, P. H., Gao, W., Ding, X. R., Lun, Y. Q., Liang, R., He, Z. H., Yang, Q., & Lu, L. J. (2022). Treatment with the ferroptosis inhibitor Ferrostatin-1 attenuates noise-induced hearing loss by suppressing ferroptosis and apoptosis. Oxidative Medicine and Cellular Longevity, 2022, Article 3373828.","journal-title":"Oxidative Medicine and Cellular Longevity"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-025-05535-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-025-05535-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-025-05535-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T21:01:53Z","timestamp":1773781313000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-025-05535-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["5535"],"URL":"https:\/\/doi.org\/10.1007\/s12010-025-05535-3","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"10 December 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study involving human samples was conducted in accordance with the ethical principles of the Declaration of Helsinki and was approved by the Clinical Research Ethics Committee of Wuhan University People\u2019s Hospital (No. 2024\u00a0K-K182(C01)). All experiments involving animals were conducted in accordance with the ARRIVE Guidelines 2.0 and were approved by the Ethics Committee of Renmin Hospital of Wuhan University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}